It starts with a sneeze. Someone on the subway didn't cover their mouth and now a cloud of invisible invaders hangs in the ...
Alzheimer’s disease affects over 55 million people worldwide and has long been linked to toxic protein buildup and chronic inflammation in the brain.
Explore how adaptive immunity influences Alzheimer’s disease, its impact on disease progression, and potential therapeutic ...
GW Cancer Center to initiate Phase II trial evaluating neoadjuvant efti as monotherapy and in combination with chemotherapy prior to surgery in ...
TATUM bioscience, a preclinical biotechnology company developing a new immunotherapy to fight cancer, announced the ...
Macrophages rely on lysosomes to balance microbial killing with self-protection, generating reactive oxygen and nitrogen ...
News-Medical.Net on MSN
Lysosomal acidity fine-tunes reactive species production in macrophages
Macrophages rely on lysosomes to balance microbial killing with self-protection, generating reactive oxygen and nitrogen ...
Third patient in the first cohort is now advancing through protocol-defined evaluations as Company anticipates additional results from second ...
Techno-Science.net on MSN
🎯 A promising strategy against aggressive breast cancer
A groundbreaking study conducted by researchers from McGill University, the Lady Davis Institute for Medical Research (LDI) ...
Understanding the intricate workings of a chicken's gastrointestinal tract is crucial for optimising their health and ...
IMNN-001 continues to show a favorable safety profile.
Sherbrooke, Que.-based medtech startup Tatum Bioscience has demonstrated promising results for its immunotherapy that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results